1) Chronic myelogenous leukemia
慢性粒细胞性白血病
1.
The Primary Syudy of Biologicla Characteristics of Tumor Stem Cells-derived from Bone Marrow of Patients with Chronic Myelogenous Leukemia;
慢性粒细胞性白血病患者骨髓源肿瘤干细胞生物学特性的研究
2.
Expression and regulation of Bim protein in chronic myelogenous leukemia
慢性粒细胞性白血病中Bim蛋白表达及调控研究
3.
Molecularly targeted agent imatinib can successfully control chronic myelogenous leukemia by combining to Bcr-Abl kinase.
分子靶向药物伊马替尼能够与Bcr-Abl激酶结合而成功治疗慢性粒细胞性白血病,然而该激酶的点突变常导致伊马替尼耐药,使治疗失败。
2) Chronic myeloid leukemia
慢性粒细胞性白血病
1.
Detection and analysis of chromosome aberration from 27 cases of chronic myeloid leukemia
27例慢性粒细胞性白血病染色体畸变分析
2.
Objective: To study the combination of morphological and immunophenotype diagnosis in chronic myeloid leukemia at different phases.
目的 :探讨慢性粒细胞性白血病 ( CML )不同病期患者的形态学和免疫学表型联合诊断分型。
3.
Chronic myeloid leukemia (CML) , a decease generated by tumor proliferation of multiple-stem cells, has the principal clinical symptoms as asthenia, weight losing, fever, bone pains, swollen liver , spleen and lymphatic nodes .
慢性粒细胞性白血病(Chronic myeloid leukemia,CML,简称慢粒)是一种起源于多能干细胞的肿瘤性增生性疾病,临床上以乏力,消瘦,发热,肝、脾、淋巴结肿大和骨痛为主要症状。
3) chronic granulocytic leukemia
慢性粒细胞性白血病
1.
Methods MICA*008 allele was detected in 86 patients with chronic granulocytic leukemia and 81 unrelated normal individuals by way of sequence-specific primers (PCR-SSP).
目的研究慢性粒细胞性白血病(CGL)MICA*008基因与HCMV感染的相关性。
2.
Objective]To analyse the therapeutic effect of qinggan huayu(purging liver and eliminating stasis) decoction on patients with chronic granulocytic leukemia and the effect on its influence on psychological factors,and to discuss the mechanism of qinggan huayu decoction on CGL from the point of view of psychosomatic medicine.
[目的]分析清肝化瘀汤为主治疗慢性粒细胞性白血病(CML)的疗效及其对患者心理因素的影响,从心身医学角度探讨清肝化瘀汤治疗CML的疗效机制。
4) CML
慢性粒细胞性白血病
1.
Objective To examine the expression levels of P16 in the patients with chronic myelogenous leukemia(CML),and evaluate the pathogenesis and clinical significance of P16 in CML.
目的检测细胞周期调控因子P16在慢性粒细胞性白血病(CML)患者中的表达,探讨P16在CML中的作用机制及临床意义。
2.
To study the change of fluorimetric behavior of a DNA probe after hybridization, a combination of DNA hairpin structure with a pair of fluorophore and quencher (molecular beacon, MB) was designed according to the DNA sequences relating to Chronic Myelogenous Leukemia (CML, Type b3a2) and a novel method for the determination of type b3a2 gene was established.
根据慢性粒细胞性白血病(CML)相关基因b3a2序列设计了一种带有荧光基团和淬灭基团的凸环结构探针(分子信标,MB),研究其与互补目标DNA杂交前后的荧光变化行为,建立了b3a2基因检测的新方法。
5) chronic myelogenous leukemia
慢性粒细胞白血病
1.
Application of dual-color fluorescence in situ hybridization to study on deletions of derivative chromosome 9 in chronic myelogenous leukemia.;
应用双色荧光原位杂交检测慢性粒细胞白血病衍生9号染色体缺失的研究
2.
Health education of patients with chronic myelogenous leukemia;
慢性粒细胞白血病患者健康教育的实施
3.
Generation of dendritic cells from peripheral blood of patients with chronic myelogenous leukemia;
慢性粒细胞白血病树突状细胞的体外定向诱导扩增及鉴定
6) chronic myelocytic leukemia
慢性粒细胞白血病
1.
Clinical significance of the changes of the serum lactate dehydrogenase,α-hydroxybutyrate dehydrogenase,alkaliphosphatase in the patients with chronic myelocytic leukemia;
慢性粒细胞白血病患者血清乳酸脱氢酶、α-羟丁酸脱氢酶、碱性磷酸酶水平变化的临床意义
2.
Case reports on 6 patients with chronic myelocytic leukemia treated with complex capsules of Qinghuang;
复方青黄胶囊治疗慢性粒细胞白血病6例临床报道
3.
Allogeneic peripheral blood stem cell transplantation with low dose pretreatment in chronic myelocytic leukemia;
低预处理剂量异基因外周造血干细胞移植治疗慢性粒细胞白血病
补充资料：慢性粒细胞性白血病
慢性粒细胞性白血病
chronic granulocytic leukemia,CML
慢性白血病中最常见的一种类型。起病缓慢，自发病到就诊时间多在半年至一年。临床表现除全身有低热、出汗及消瘦外，还有肝睥肿大、胸骨压痛、出血、淋巴结轻度至中度肿大等。部分可发生*慢粒急性变。可用*马利兰、环磷酰胺、羟基脲、琉嘌呤等药物联合治疗，以及放射治疗和手术脾切除等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条